No Major Adverse Events In 2 Phases Of Covaxin Trials: Bharat Biotech ...Middle East

Ommcom News - News
No Major Adverse Events In 2 Phases Of Covaxin Trials: Bharat Biotech
Hyderabad:  Bharat Biotech, which recently received approval to conduct Phase III human trials of India’s first indigenous coronavirus vaccine, Covaxin, has said that the vaccine has been found to be safe without any major adverse events in the first two stages of trials and that its goal is to attain strong immune response rate in … The post No Major Adverse Events In 2 Phases Of Covaxin Trials: Bharat Biotech appeared first on Ommcom News.

Hence then, the article about no major adverse events in 2 phases of covaxin trials bharat biotech was published today ( ) and is available on Ommcom News ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( No Major Adverse Events In 2 Phases Of Covaxin Trials: Bharat Biotech )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News